RICE HALL JAMES & ASSOCIATES, LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1230765
San Diego, CA
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,456,182
New position
Shares Held
251,066
first reported quarter
Ownership
0.145%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $163,984,394 across 13 Drug Manufacturers - Specialty & Generic names. XERS ranks #13 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBH |
Prestige Consumer Healthcare Inc.
|
521,622 | $30,916,535 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
608,416 | $29,295,230 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
477,416 | $24,677,633 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,230,105 | $21,230,599 | |
| 5 | ALKS |
Alkermes plc.
|
390,344 | $13,802,563 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
99,990 | $13,172,682 | |
| 7 | HROW |
Harrow, Inc.
|
368,177 | $12,981,921 | |
| 8 | EOLS |
Evolus, Inc.
|
1,254,819 | $5,157,306 |
All Filings in XERS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,456,182 | 251,066 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||